Product details
System overview
Helpful features and support
Share your CGM data with your doctor
Easily share your glucose data with your doctor, so they have a full view of your trends—even between visits.
Connected partners
Dexcom G7 CGM Systems are made for connections that seamlessly fit into your life. From digital health partners, insulin delivery systems** and connected devices, Dexcom CGM helps make diabetes management more customizable and convenient than ever.
Get Dexcom G7 at your local pharmacy
Pick up your Dexcom G7 15 Day supplies from your pharmacy with a prescription from your doctor. Dexcom G7 15 Day is covered by some provincial and private plans,¶¶ with many being added over the coming months.
Dexcom Savings Program
Save up to 20% off the out-of-pocket cost for Dexcom G7 15 Day sensor purchases at any pharmacy.## This program can be applied towards your insurance copay, deductible, or non-insurance cash purchases, which can reduce or even eliminate out-of-pocket costs.
*Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
†Smart device sold separately. For a list of compatible devices, visit dexcom.com/compatibility. ‡96% of patient reported painless sensor insertion (mild, no pain). §Provides a warning up to 20 minutes in advance of severe hypoglycemia (glucose levels at or below 55 mg/dL). ||Event logging only available in the Dexcom G7 app. ¶Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. #Smartphone required to display readings on watch. **To learn more about insulin pump integrations and compatibility with Dexcom CGM Systems, visit www.dexcom.com/en-CA/partnerships/integrations-and-compatibility. ††Percentage was based on the evaluation of 171 sensors. ‡‡55% of participants surveyed wore Dexcom CGM. §§1.4% reduction in A1C at 26 weeks, compared with 0.2% with routine care and GLP-1 alone. ¶¶Eligibility and coverage vary by policy, plan, and payor. ##Based on reasonable upcharge, mark-up and customary pharmacy dispensing fee.
†Smart device sold separately. For a list of compatible devices, visit dexcom.com/compatibility. ‡96% of patient reported painless sensor insertion (mild, no pain). §Provides a warning up to 20 minutes in advance of severe hypoglycemia (glucose levels at or below 55 mg/dL). ||Event logging only available in the Dexcom G7 app. ¶Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. #Smartphone required to display readings on watch. **To learn more about insulin pump integrations and compatibility with Dexcom CGM Systems, visit www.dexcom.com/en-CA/partnerships/integrations-and-compatibility. ††Percentage was based on the evaluation of 171 sensors. ‡‡55% of participants surveyed wore Dexcom CGM. §§1.4% reduction in A1C at 26 weeks, compared with 0.2% with routine care and GLP-1 alone. ¶¶Eligibility and coverage vary by policy, plan, and payor. ##Based on reasonable upcharge, mark-up and customary pharmacy dispensing fee.
1 Dexcom G7 15 Day User Guide. 2 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 3 Dexcom, data on file, 2026. 4 Garg SK, et al. Diabetes Technol Ther. 2025;27(6):413-502. 5 Ehrhardt N, et al. Clin Diabetes. 2020:38(2):126-131. 6 Clark TL, et al. Diabetes Technol Ther. 2024;26(10):700-8. 7 Beck, RW, et al. JAMA. 2017;317(4):371-378. 8 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 9 Martens T, et al. JAMA. 2021;325(22):2262-2272 10. Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 11 Grace TP, et al. Clinical Diabetes. 2024;42(4):540-6. 12 Gilbert TR, Diabetes Technol Ther. 2021;23(S1):S35-S9. 13 Oser T, et al. CGM for Adults with Type 2 Diabetes Not on Insulin: The CONNECT Randomized Controlled Trial. Presented at the 2026 Scientific Sessions of the American Diabetes Association, June 6, 2026. New Orleans, LA; USA.